Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

COMPREHENSIVE PAIN MANAGEMENT, LLC

NPI: 1962410621 · MANASQUAN, NJ 08736 · Pain Medicine Physician · NPI assigned 08/04/2006

$140K
Total Medicaid Paid
7,824
Total Claims
7,384
Beneficiaries
31
Codes Billed
2018-01
First Month
2019-12
Last Month

Provider Details

Authorized OfficialLEPIS, MICHAEL (OWNER)
NPI Enumeration Date08/04/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 4,109 $75K
2019 3,715 $65K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 529 516 $53K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 545 530 $39K
99152 396 371 $19K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 549 528 $16K
72100 321 309 $10K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 29 28 $731.33
20610 13 13 $586.68
72040 15 14 $544.48
99153 Mod sedat endo service >5yrs 46 45 $401.21
J7120 Ringers lactate infusion, up to 1000 cc 148 139 $357.67
96103 130 128 $176.70
J2250 Injection, midazolam hydrochloride, per 1 mg 149 140 $151.00
J3010 Injection, fentanyl citrate, 0.1 mg 132 124 $131.78
96146 16 16 $17.52
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 55 54 $16.00
J3490 Unclassified drugs 413 383 $14.48
81002 587 556 $2.00
G8542 Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required 56 50 $0.00
1036F 814 763 $0.00
G9717 Documentation stating the patient has had a diagnosis of bipolar disorder 15 15 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 475 436 $0.00
G9584 Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy 374 347 $0.00
G9562 Patients who had a follow-up evaluation conducted at least every three months during opioid therapy 372 346 $0.00
G8730 Pain assessment documented as positive using a standardized tool and a follow-up plan is documented 478 439 $0.00
77003 555 523 $0.00
G9578 Documentation of signed opioid treatment agreement at least once during opioid therapy 373 346 $0.00
4004F 29 29 $0.00
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 75 68 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 29 29 $0.00
G8783 Normal blood pressure reading documented, follow-up not required 71 66 $0.00
G8539 Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment 35 33 $0.00